Skip to content
Discover the best bonus offers and rewards at Smart Bonus L…

Patients Discontinuing Weight-Loss Injections Gain Back Pounds Far More Rapidly Compared to Dieters

Image of medical injection and weighing machine
Weight management involves ongoing approaches.

Fresh analysis indicates that people who stop using blockbuster slimming jabs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end traditional diet and exercise plans.

Published data in a leading medical journal shows that while overweight individuals often shed substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"People buying such medications must be informed of the risk of quick rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.

That rate of regain means a reversion to starting weight in about 18 months.

Analyzing Approaches

The research, which examined 37 of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

The team note that individuals who lose weight through dieting generally see a slower creep back—around 100 grams monthly—post-intervention.

Explaining the Quick Rebound

Doctors propose the mode of action of the jabs is key to understanding the amplified weight return.

These medications imitate a body's own chemical called GLP-1, which controls hunger.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication means appetite is unsuppressed, making binge eating far more likely."

A Lifelong Disease?

Medical guidelines suggest the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

A number of clinicians contend that, due to the significant potential of relapse, the therapy might need to be ongoing.

This opinion is echoed by drug manufacturers, who note that the results "emphasize the persistent character of obesity," comparing it to managing diseases like hypertension.

Patient Experiences

Users who have discontinued the jabs report a sudden resurgence of appetite.

"It felt as if something activating and I was suddenly ravenous," said one woman.

The struggle is exacerbated if patients have not developed sustainable lifestyle or habit changes during therapy.

Widespread Adoption

Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.

  • Adoption is greater among females compared to men.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

Ultimately, experts caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone solution and maintained weight loss relies on integrated lifestyle changes.

DR
Written by

David Rice

A seasoned deal hunter and financial blogger who loves sharing ways to save money and earn rewards.

Smart Bonus Link

Type to search articles.